Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relati...
Saved in:
Published in | PloS one Vol. 20; no. 4; p. e0302766 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
03.04.2025
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma. |
---|---|
AbstractList | As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma.As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma. As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma. As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma. |
Audience | Academic |
Author | Liu, Li Tong, Wangxia Qin, Na Luo, Ning Liu, Rong Lu, Tao Chen, Jibing |
AuthorAffiliation | 1 Department of Hepatology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China 3 Department of hepatobiliary surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China King Faisal Specialist Hospital and Research Center, Saudi Arabia 4 Centre for Translational Medical Research in Integrative Chinese and Western Medicine, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China 2 The Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China 5 Department of Neurology, RuiKang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China |
AuthorAffiliation_xml | – name: 5 Department of Neurology, RuiKang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China – name: 2 The Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China – name: 4 Centre for Translational Medical Research in Integrative Chinese and Western Medicine, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China – name: 3 Department of hepatobiliary surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China – name: King Faisal Specialist Hospital and Research Center, Saudi Arabia – name: 1 Department of Hepatology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China |
Author_xml | – sequence: 1 givenname: Wangxia surname: Tong fullname: Tong, Wangxia – sequence: 2 givenname: Na surname: Qin fullname: Qin, Na – sequence: 3 givenname: Tao surname: Lu fullname: Lu, Tao – sequence: 4 givenname: Li surname: Liu fullname: Liu, Li – sequence: 5 givenname: Rong surname: Liu fullname: Liu, Rong – sequence: 6 givenname: Jibing surname: Chen fullname: Chen, Jibing – sequence: 7 givenname: Ning orcidid: 0000-0002-3892-524X surname: Luo fullname: Luo, Ning |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40179068$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk11v0zAUhiM0xLbCP0BgCQnBRVs7TmznClXjY9UmirrCreU4zsdI4mI7hf4PfjAOzaYG7QJFSpyT57wnfn3OeXDS6lYFwXMEZwhTNL_VnWlFPdv68AxiGFJCHgVnKMHhlIQQnxytT4Nza28hjDEj5ElwGkFEE0jYWfB72TpVGOGqtgBpV38Hos2A9W-1mkpV12D9eQGs-tGpVvaMUTslagtuLvH7EIGt0Y12yoJSbYXTfUZXCwOkMB7XjeiJwihrK92CdA-EdNXuUM6VCnxZ4qv54mozbzarNfAS5U-xfxo8zn0N9Wx4ToKvHz9sLi6n16tPy4vF9VSSKHJTlCFKQ5amkOFYMsyoTBDNMc5jwVhO0pxFWRiyECmKBA5Tz2ZRkpOEZjBSEk-Clwfdba0tHwy1HCNGwgRFCfXE8kBkWtzyrakaYfZci4r_DWhTcGFcJWvFfUpCcpqmGVIRjWkSRzAJERYszUOa9Vrvhmpd2qhMqtYZUY9Ex1_aquSF3nGEEkITAr3Cm0HBaH8g1vGmsr3lolW6O_w4jhH25zwJXv2DPry9gSqE30HV5toXlr0oXzCMGST-5qnZA5S_MtVU0rdfXvn4KOHtKMEzTv1yheis5cub9f-zq29j9vURW_o-dKXVded8b9kx-OLY6nuP7_reA9EBkEZba1R-jyDI-_G6s4v348WH8cJ_AHyKFjQ |
Cites_doi | 10.1016/j.cell.2017.04.001 10.3390/biomedicines9111639 10.1038/s41568-018-0074-8 10.4049/jimmunol.1601515 10.1038/nri.2016.80 10.1016/S0140-6736(18)30010-2 10.1016/j.semcancer.2019.07.003 10.1093/annonc/mdv474 10.3748/wjg.v24.i31.3500 10.1101/cshperspect.a006098 10.1053/j.semdp.2016.12.011 10.1038/s41587-020-0546-8 10.1146/annurev-immunol-032712-095946 10.3390/nu14010067 10.1038/s41598-019-55893-2 10.1093/nar/gkac947 10.1002/hep.31288 10.1186/s40608-017-0145-5 10.3389/fonc.2014.00064 10.3390/ijms21124414 10.1038/s41392-021-00484-9 10.1007/978-1-0716-1307-8_19 10.1158/2159-8290.CD-12-0095 10.1093/nar/gkz401 10.1016/S1470-2045(21)00604-5 10.1056/NEJMra1713263 10.1016/S1470-2045(22)00326-6 10.1038/s41575-022-00704-9 10.1038/s41467-022-32283-3 10.1177/0022034520910127 10.1007/s11912-022-01247-7 10.1038/nmeth.4402 10.1038/nature13490 10.1038/nature19834 |
ContentType | Journal Article |
Copyright | Copyright: © 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2025 Public Library of Science 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2025 Tong et al 2025 Tong et al 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Copyright: © 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2025 Public Library of Science – notice: 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2025 Tong et al 2025 Tong et al – notice: 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0302766 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed In Context: Opposing Viewpoints In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agriculture Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Agricultural Science Database CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
DocumentTitleAlternate | SH3D21 promotes hepatocellular carcinoma progression |
EISSN | 1932-6203 |
ExternalDocumentID | 3186291497 oai_doaj_org_article_62996f7bbd1e475795409213a8bf27d7 PMC11967960 A833806338 40179068 10_1371_journal_pone_0302766 |
Genre | Journal Article |
GeographicLocations | China United States Massachusetts Illinois United States--US |
GeographicLocations_xml | – name: China – name: United States – name: Massachusetts – name: Illinois – name: United States--US |
GrantInformation_xml | – grantid: none – grantid: 2021GXNSFAA196031 – fundername: ; grantid: 82060843 – fundername: ; grantid: 82260860 |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM ADRAZ BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c644t-1d17728bb0835c8387c917f33f5a88f6bf84d22821e71a32b28bd49f697d04ec3 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Wed Aug 13 01:18:50 EDT 2025 Wed Aug 27 01:20:21 EDT 2025 Thu Aug 21 18:38:16 EDT 2025 Fri Jul 11 18:50:20 EDT 2025 Fri Jul 25 11:15:05 EDT 2025 Tue Jun 17 21:58:05 EDT 2025 Tue Jun 10 20:58:41 EDT 2025 Fri Jun 27 05:14:47 EDT 2025 Fri Jun 27 05:14:36 EDT 2025 Thu May 22 21:23:44 EDT 2025 Sat May 17 01:30:15 EDT 2025 Tue Jul 01 05:14:33 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | Copyright: © 2025 Tong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c644t-1d17728bb0835c8387c917f33f5a88f6bf84d22821e71a32b28bd49f697d04ec3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 JC and NL also contributed equally to this work. Competing Interests: The authors have declared that no competing interests exist. |
ORCID | 0000-0002-3892-524X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0302766 |
PMID | 40179068 |
PQID | 3186291497 |
PQPubID | 1436336 |
PageCount | e0302766 |
ParticipantIDs | plos_journals_3186291497 doaj_primary_oai_doaj_org_article_62996f7bbd1e475795409213a8bf27d7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11967960 proquest_miscellaneous_3186351305 proquest_journals_3186291497 gale_infotracmisc_A833806338 gale_infotracacademiconefile_A833806338 gale_incontextgauss_ISR_A833806338 gale_incontextgauss_IOV_A833806338 gale_healthsolutions_A833806338 pubmed_primary_40179068 crossref_primary_10_1371_journal_pone_0302766 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-04-03 |
PublicationDateYYYYMMDD | 2025-04-03 |
PublicationDate_xml | – month: 04 year: 2025 text: 2025-04-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2025 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | C Porta (pone.0302766.ref011) 2014; 4 Y Sunakawa (pone.0302766.ref034) 2015; 26 G Giannone (pone.0302766.ref025) 2020; 21 JN Hellwege (pone.0302766.ref015) 2017; 4 A Villanueva (pone.0302766.ref001) 2019; 380 C-F Tsai (pone.0302766.ref028) 2021; 14 X Qiu (pone.0302766.ref021) 2017; 14 X Xiang (pone.0302766.ref035) 2021; 6 MJ Goldman (pone.0302766.ref017) 2020; 38 DE Speiser (pone.0302766.ref027) 2016; 16 MM Kaneda (pone.0302766.ref030) 2016; 539 X Wu (pone.0302766.ref031) 2020; 99 T Yau (pone.0302766.ref006) 2022; 23 R Sever (pone.0302766.ref009) 2015; 5 K Okkenhaug (pone.0302766.ref026) 2013; 31 EJ Sun (pone.0302766.ref010) 2021; 9 X-N Yu (pone.0302766.ref012) 2019 Q Zhang (pone.0302766.ref029) 2018; 24 Y Lu (pone.0302766.ref022) 2022; 13 KA McGlynn (pone.0302766.ref007) 2021 J Hartke (pone.0302766.ref004) 2017; 34 C Hu (pone.0302766.ref020) 2023; 51 AK Murugan (pone.0302766.ref014) 2019; 59 Y Liao (pone.0302766.ref018) 2019; 47 S Slovin (pone.0302766.ref019) 2021 BD Manning (pone.0302766.ref008) 2017; 169 E Vergadi (pone.0302766.ref032) 2017; 198 OR Colegio (pone.0302766.ref033) 2014; 513 M Masoudi (pone.0302766.ref023) 2019; 9 C Yang (pone.0302766.ref013) 2023; 20 E Cerami (pone.0302766.ref016) 2012; 2 A Forner (pone.0302766.ref002) 2018; 391 RK Kelley (pone.0302766.ref005) 2022; 23 KM Wong (pone.0302766.ref003) 2022; 24 D Mossmann (pone.0302766.ref024) 2018; 18 |
References_xml | – volume: 169 start-page: 381 issue: 3 year: 2017 ident: pone.0302766.ref008 article-title: AKT/PKB signaling: navigating the network publication-title: Cell doi: 10.1016/j.cell.2017.04.001 – volume: 9 start-page: 1639 issue: 11 year: 2021 ident: pone.0302766.ref010 article-title: Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma publication-title: Biomedicines doi: 10.3390/biomedicines9111639 – volume: 18 start-page: 744 issue: 12 year: 2018 ident: pone.0302766.ref024 article-title: mTOR signalling and cellular metabolism are mutual determinants in cancer publication-title: Nat Rev Cancer doi: 10.1038/s41568-018-0074-8 – volume: 198 start-page: 1006 issue: 3 year: 2017 ident: pone.0302766.ref032 article-title: Akt signaling pathway in macrophage activation and M1/M2 polarization publication-title: J Immunol doi: 10.4049/jimmunol.1601515 – volume: 16 start-page: 599 issue: 10 year: 2016 ident: pone.0302766.ref027 article-title: Regulatory circuits of T cell function in cancer publication-title: Nat Rev Immunol doi: 10.1038/nri.2016.80 – volume: 391 start-page: 1301 issue: 10127 year: 2018 ident: pone.0302766.ref002 article-title: Hepatocellular carcinoma publication-title: Lancet doi: 10.1016/S0140-6736(18)30010-2 – volume: 59 start-page: 92 year: 2019 ident: pone.0302766.ref014 article-title: mTOR: Role in cancer, metastasis and drug resistance publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2019.07.003 – volume: 26 start-page: 2450 issue: 12 year: 2015 ident: pone.0302766.ref034 article-title: Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials publication-title: Ann Oncol doi: 10.1093/annonc/mdv474 – volume: 24 start-page: 3500 issue: 31 year: 2018 ident: pone.0302766.ref029 article-title: Immunometabolism: a novel perspective of liver cancer microenvironment and its influence on tumor progression publication-title: World J Gastroenterol doi: 10.3748/wjg.v24.i31.3500 – volume: 5 start-page: a006098 issue: 4 year: 2015 ident: pone.0302766.ref009 article-title: Signal transduction in cancer publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a006098 – volume: 34 start-page: 153 issue: 2 year: 2017 ident: pone.0302766.ref004 article-title: The diagnosis and treatment of hepatocellular carcinoma publication-title: Semin Diagn Pathol doi: 10.1053/j.semdp.2016.12.011 – volume: 38 start-page: 675 issue: 6 year: 2020 ident: pone.0302766.ref017 article-title: Visualizing and interpreting cancer genomics data via the Xena platform publication-title: Nat Biotechnol doi: 10.1038/s41587-020-0546-8 – volume: 31 start-page: 675 year: 2013 ident: pone.0302766.ref026 article-title: Signaling by the phosphoinositide 3-kinase family in immune cells publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-032712-095946 – volume: 14 start-page: 67 issue: 1 year: 2021 ident: pone.0302766.ref028 article-title: Regulatory effects of quercetin on M1/M2 macrophage polarization and oxidative/antioxidative balance publication-title: Nutrients doi: 10.3390/nu14010067 – volume: 9 start-page: 19188 issue: 1 year: 2019 ident: pone.0302766.ref023 article-title: A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine publication-title: Sci Rep doi: 10.1038/s41598-019-55893-2 – volume: 51 start-page: D870 issue: D1 year: 2023 ident: pone.0302766.ref020 article-title: CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data publication-title: Nucleic Acids Res doi: 10.1093/nar/gkac947 – start-page: 4 issue: Suppl 1 year: 2021 ident: pone.0302766.ref007 article-title: Epidemiology of hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.31288 – volume: 4 start-page: 12 year: 2017 ident: pone.0302766.ref015 article-title: Association of gene coding variation and resting metabolic rate in a multi-ethnic sample of children and adults publication-title: BMC Obes doi: 10.1186/s40608-017-0145-5 – volume: 4 start-page: 64 year: 2014 ident: pone.0302766.ref011 article-title: Targeting PI3K/Akt/mTOR signaling in cancer publication-title: Front Oncol doi: 10.3389/fonc.2014.00064 – volume: 21 start-page: 4414 issue: 12 year: 2020 ident: pone.0302766.ref025 article-title: Immuno-metabolism and microenvironment in cancer: key players for immunotherapy publication-title: Int J Mol Sci doi: 10.3390/ijms21124414 – volume: 6 start-page: 75 issue: 1 year: 2021 ident: pone.0302766.ref035 article-title: Targeting tumor-associated macrophages to synergize tumor immunotherapy publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-021-00484-9 – start-page: 343 year: 2021 ident: pone.0302766.ref019 article-title: Single-cell RNA sequencing analysis: a step-by-step overview publication-title: Methods Mol Biol doi: 10.1007/978-1-0716-1307-8_19 – volume: 2 start-page: 401 issue: 5 year: 2012 ident: pone.0302766.ref016 article-title: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-12-0095 – volume: 47 start-page: W199 issue: W1 year: 2019 ident: pone.0302766.ref018 article-title: WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs publication-title: Nucleic Acids Res doi: 10.1093/nar/gkz401 – volume: 23 start-page: 77 issue: 1 year: 2022 ident: pone.0302766.ref006 article-title: Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(21)00604-5 – volume: 380 start-page: 1450 issue: 15 year: 2019 ident: pone.0302766.ref001 article-title: Hepatocellular carcinoma publication-title: N Engl J Med doi: 10.1056/NEJMra1713263 – volume: 23 start-page: 995 issue: 8 year: 2022 ident: pone.0302766.ref005 article-title: Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(22)00326-6 – volume: 20 start-page: 203 issue: 4 year: 2023 ident: pone.0302766.ref013 article-title: Evolving therapeutic landscape of advanced hepatocellular carcinoma publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-022-00704-9 – volume: 13 start-page: 4594 issue: 1 year: 2022 ident: pone.0302766.ref022 article-title: A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma publication-title: Nat Commun doi: 10.1038/s41467-022-32283-3 – volume: 99 start-page: 577 issue: 5 year: 2020 ident: pone.0302766.ref031 article-title: Akt2 affects periodontal inflammation via altering the M1/M2 ratio publication-title: J Dent Res doi: 10.1177/0022034520910127 – start-page: 379 issue: 2 year: 2019 ident: pone.0302766.ref012 article-title: Targeting the mTOR regulatory network in hepatocellular carcinoma: are we making headway? publication-title: Biochim Biophys Acta Rev Cancer – volume: 24 start-page: 917 issue: 7 year: 2022 ident: pone.0302766.ref003 article-title: The treatment landscape of advanced hepatocellular carcinoma publication-title: Curr Oncol Rep doi: 10.1007/s11912-022-01247-7 – volume: 14 start-page: 979 issue: 10 year: 2017 ident: pone.0302766.ref021 article-title: Reversed graph embedding resolves complex single-cell trajectories publication-title: Nat Methods doi: 10.1038/nmeth.4402 – volume: 513 start-page: 559 issue: 7519 year: 2014 ident: pone.0302766.ref033 article-title: Functional polarization of tumour-associated macrophages by tumour-derived lactic acid publication-title: Nature doi: 10.1038/nature13490 – volume: 539 start-page: 437 issue: 7629 year: 2016 ident: pone.0302766.ref030 article-title: PI3Kγ is a molecular switch that controls immune suppression publication-title: Nature doi: 10.1038/nature19834 |
SSID | ssj0053866 |
Score | 2.4778185 |
Snippet | As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21... As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21... |
SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e0302766 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase Adaptor Proteins, Signal Transducing - genetics Adaptor Proteins, Signal Transducing - metabolism AKT protein Analysis Bioinformatics Biological effects Biology and Life Sciences Biomarkers Biomarkers, Tumor - genetics Cancer Cancer therapies Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology Cell cycle Cell Line, Tumor Cell Movement - genetics Cell Proliferation - genetics Chemotherapy Cholecystokinin Datasets Development and progression Disease Progression Female Gene expression Gene Expression Regulation, Neoplastic Gene sequencing Genes Genetic aspects Genomes Genomics Health aspects Hepatocellular carcinoma Hepatoma Humans Immunotherapy Kinases Liver cancer Liver Neoplasms - genetics Liver Neoplasms - metabolism Liver Neoplasms - pathology Male Medical prognosis Medicine and Health Sciences Membrane proteins Metabolism Oncology, Experimental Phosphatidylinositol 3-Kinases - genetics Phosphatidylinositol 3-Kinases - metabolism Prognosis Protein kinases Proto-Oncogene Proteins c-akt - genetics Proto-Oncogene Proteins c-akt - metabolism Quality control RNA RNA sequencing Sequence Analysis, RNA Signal Transduction Single-Cell Analysis Software Therapeutic targets TOR protein TOR Serine-Threonine Kinases - genetics TOR Serine-Threonine Kinases - metabolism Traditional Chinese medicine Tumor microenvironment Tumor Microenvironment - genetics Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdQn3hBjK8VChiEBDxkbWwndh_Lx9SC2FC3ob1ZduwwRJdUtAXt_-AP5i52w4ImwQOv9cWu787n3yXnnwl5hiRh1jifSOFNIlLHE8M5hyyFWeWsyhzDA84fDvLpiXh3mp1euuoLa8ICPXBQ3DCHeJmX0lqXeiEzOQaIMYYRjLIlk645Rw573jaZCjEYVnGex4NyXKbDaJe9ZV35vRF-qmtYEX9vRA1ffxuVe8tFvboKcv5ZOXlpK9q_SW5EDEkn4b_vkGu-ukV24ipd0ReRSvrlbfJzFtkgYIOidrP4Sk3lKL4eWPgE39nT-cGExnJqlEFCJ3BIejTlb1hKl02xHvR5BrvWusYnsGyVFngDUVWfG9rUdwVuD2ovKB6T-B6GA2RJP874-yHAyOH58eGc4u3HP8zFHXKy__b49TSJ9zAkBaCldZK6FDC4shbhWqG4kgUkeSXnZWaUKnNbKuEY5G6pl6nhzIKsE-MyH0s3Er7gd0mvAs3vEmoyQBCeOSZyI5D93TAFCMyrwjsF_fVJsjWKXga6Dd18c5OQpgTtajSijkbsk1douVYWybKbH8CFdHQh_TcX6pPHaHcdTp62S15PFOTvAOG46pOnjQQSZlRYkfPZbFYrPTv89A9CR_OO0PMoVNbgQYWJpyBgTkjE1ZEcdCRh2Red5l300q1WVhqCM0wUEl6Yz2DruVc3P2mbsVOssqt8vQkyPANUA3a4Fxy91azA0D3KYVzVWQId1Xdbqi9nDV95ClFeQqZ8_38Y6wG5zvAKZiye4gPSW3_b-IeAC9f2URMCfgEg7l9O priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegvPCCGF8rG2AQEvCQtbGT2HlC5aO0IDbUbWhvkR07G6JLsqUF7f_gD-YucTKCJsRrfXEa3539O_v8O0KeI0mYVsZ6IrDKC3zDPcU5hyiFaWm0DA3DC86fd6PZYfDxKDxyG26VS6ts58R6ojZFinvkI7C9iMWA58Xr8szDqlF4uupKaFwnN3xYaTClS04_tDMx-HIUuetyXPgjp52dssjtzhgP7GpuxMvlqGbt7-bmQbksqquA59_5k38sSNPb5JZDknTSqH6DXLP5HbLhfLWiLx2h9Ku75NfccULAMkX1evmdqtxQ3CRYWg937ulid0JdUjXKIK0TmCXdn_F3zKdlnbIHfZ7A2rUq8AlMXqUp1iHKi1NF6yyvhuGD6guKlyV-NK8DfEm_zPmnEYDJ0enB3oJiDeSf6uIeOZy-P3g781w1Bi8FzLTyfOMDEpdaI2hLJZcihVAv4zwLlZRZpDMZGAYRnG-FrzjTIGuCOItiYcaBTfl9Mshh5DcJVSHgCMsMCyIVIAe8YhJwmJWpNRL6GxKvVUpSNqQbSX3yJiBYaUY3QSUmTolD8gY118kiZXb9Q3F-nDgPTMB64igTWhvfBiIUMWDVGExVSZ0xYcSQPEG9J839087xk4mEKB6AHJdD8qyWQNqMHPNyjtW6qpL53tf_ENpf9IReOKGsAAtKlbsLAd-EdFw9ye2eJDh_2mveRCttR6VKLt0Enmwt9-rmp10zdoq5drkt1o0MDwHbgB4eNIbejWyAE_g4gvfKngv0hr7fkn87qVnLfZjrBcTLD__9v7bITYYlljE5im-Twep8bR8B7lvpx7Vz_wa5DFe6 priority: 102 providerName: ProQuest |
Title | Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40179068 https://www.proquest.com/docview/3186291497 https://www.proquest.com/docview/3186351305 https://pubmed.ncbi.nlm.nih.gov/PMC11967960 https://doaj.org/article/62996f7bbd1e475795409213a8bf27d7 http://dx.doi.org/10.1371/journal.pone.0302766 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELe27oUXxPi3QikGIQEP6Zo4id0HhLrR0oLWTd069S2yY2dDdElpWqAvfAo-MHdJGhFUJMSLH-KzI9_Z59_Z5ztCXmCQMCW1sbhrpOXamlmSMQZWiqOEVsLTDj5wPhn5g4n7YepNd8gmZ2vBwHSraYf5pCaLWev7l_VbWPBvsqwN3N40as2T2LTaeBHn-7tkD_YmjjkNTtzyXgFWt-8XD-j-1rKyQWVx_EttXZvPknQbFP3To_K3Lap_h9wusCXt5pNhn-yY-C7ZL1ZvSl8VIaZf3yM_h0WUCNi4qFrNPlMZa4rHBjNj4Vk-HY-6tHCzRhoM9AQMo-cD9s6x6Txz4oM-r2E3WybYAt1ZaYiZieLkRtLM7yuP-UHVmuLzia_57wBx0rMh-3gI8PLw5uJ0TDEr8je5vk8m_d7F8cAq8jNYIaCopWVrG7C5UAphXCiY4CEYfxFjkSeFiHwVCVc7YNPZhtuSOQpotduJ_A7XbdeE7AGpxcD5A0KlB8jCONpxfeliVHjpCEBmRoRGC-ivTqyNUIJ5HoYjyO7iOJgvOXcDFGJQCLFOjlByJS0G0c4-JIuroFiTgQ9bsR9xpbRtXO7xDqDXDkxeKVTkcM3r5CnKPchfpJaqIOgKsOsB2jFRJ88zCgykEaOnzpVcpWkwPL38B6LzcYXoZUEUJTCDQlm8joAxYYCuCmWjQgnqIKxUH-As3XAlDUBpw0DBEIbxNDYzd3v1s7IaO0Xvu9gkq5yGeYB2QA4P84lectZFld724b-isgQqrK_WxJ-uszjmNmh_Dhb0o_9v-pjccjAhM7pSsQapLRcr8wRQ4lI1yS6fcijFsY1l_32T7B31RmfjZnbu0swUA5Y_er8Agh5vrw |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lc9MwENaUcIALQ3k1UKhgYICDm1iyLeXAMIESEtKmTJt2ejOSJbcMqR3qhE7-B7-D38iuHylmOgyXXqO1kmhf31r7IOQ5NgnTylhHeFY5nmu4ozjnEKUwLY2WvmFY4LwzCvoH3qcj_2iF_KpqYTCtsrKJuaE2aYTvyFsgewHrAJ4Xb6ffHZwahber1QiNQiyGdnEOIVv2ZrAF_H3BWO_D-H3fKacKOBH4_pnjGhcQpdQawUckuRQRhCwx57GvpIwDHUvPMIhEXCtcxZkGWuN14qAjTNuzEYd9r5HrHgdPjpXpvY-V5QfbEQRleR4XbquUhs1pmtjNNl4Q5r0YL9xfPiVg6Qsa00maXQZ0_87X_MMB9m6TWyVypd1C1FbJik3ukNXSNmT0VdnA-vVd8nNQ9qAAt0j1fPKNqsRQfCkxsQ7eFNC9UZeWSdxIg22kQA3ofp9vMZdO8xRB2PMEfOUsxScwWZZGOPcoSU8VzbPKio4iVC8oFmf8KL4O8Cz9PODDFoDX1ul4d4_izOVztbhHDq6ET_dJI4GTXyNU-YBbLDPMC5SHPecVk4D7rIyskbBfkzgVU8Jp0eQjzG_6BARHxemGyMSwZGKTvEPOLWmxRXf-QXp2HJYaH4K0doJYaG1c6wlfdAAbd0A1lNQxE0Y0yQbyPSzqXZeGJuxKziUARy6b5FlOgW06EswDOlbzLAsHu4f_QbS_VyN6WRLFKUhQpMraC_hP2P6rRrleowRjE9WW11BKq1PJwgu1hCcryb18-elyGTfF3L7EpvOChvuApYAPDwpBX56shw6jHcD3ypoK1I6-vpJ8Pcm7pLvgWwTE5w___bs2yI3-eGc73B6Mho_ITYbjnTExi6-Txuxsbh8D5pzpJ7miU_Llqi3Lb7pak3g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGkRAviHFbYTCDQMBD1sZOY_cBobJStRS6qdvQ3oIdOxuiS8raMvV_8Gv4dZyTOB1BE-Jlr_WJ2_rcvhOfCyHPsUmYVsZ6IrDKC3zDPcU5hyiFaWm0bBmGBc6fRmH_MPhw1DpaI7_KWhhMqyxtYm6oTRbjO_IGyF7I2oDnRSNxaRF73d7b6XcPJ0jhTWs5TqMQkaFdnkP4Nnsz6AKvXzDWe3-w0_fchAEvBhww93zjA7qUWiMQiSWXIobwJeE8aSkpk1AnMjAMohLfCl9xpoHWBO0kbAvTDGzMYd9r5LrgQqKOyZ1VegnYkTB0pXpc-A0nGdvTLLXbTbwszPsyXrjCfGLAyi_UppNsdhno_Tt38w9n2LtNbjkUSzuF2K2TNZveIevOTszoK9fM-vVd8nPg-lGAi6R6MflGVWoovqCYWA9vDeh41KEuoRtpsKUUqATd7_Mu8-k0TxeEPU_Ab84zfAITZ2mMM5DS7FTRPMOs6C5C9ZJiocaP4usA29K9AR82AMg2Tg92xxTnL5-r5T1yeCV8uk9qKZz8BqGqBRjGMsOCUAXYf14xCRjQytgaCfvViVcyJZoWDT-i_NZPQKBUnG6ETIwcE-vkHXJuRYvtuvMPsrPjyGl_BJLbDhOhtfFtIFqiDTi5DWqipE6YMKJOtpDvUVH7ujI6UUdyLgFEclknz3IKbNmRovAfq8VsFg12P_8H0f64QvTSESUZSFCsXB0G_CdsBVah3KxQguGJK8sbKKXlqcyiCxWFJ0vJvXz56WoZN8U8v9Rmi4KGtwBXAR8eFIK-OtkAnUczhO-VFRWoHH11Jf16kndM98HPCIjVH_77d22RG2BToo-D0fARuclw0jPmaPFNUpufLexjgJ9z_STXc0q-XLVh-Q044pd5 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Integrating+bulk+and+single-cell+RNA+sequencing+reveals+SH3D21+promotes+hepatocellular+carcinoma+progression+by+activating+the+PI3K%2FAKT%2FmTOR+pathway&rft.jtitle=PloS+one&rft.au=Tong%2C+Wangxia&rft.au=Qin%2C+Na&rft.au=Lu%2C+Tao&rft.au=Liu%2C+Li&rft.date=2025-04-03&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=20&rft.issue=4&rft_id=info:doi/10.1371%2Fjournal.pone.0302766&rft.externalDocID=PMC11967960 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |